title: Performance characteristics of a positron projection imager for mouse whole-body imaging.
abstract: BACKGROUND
  We describe a prototype positron projection imager (PPI) for visualizing the whole-body biodistribution of positron-emitting compounds in mouse-size animals. The final version of the PPI will be integrated into the MONICA portable dual-gamma camera system to allow the user to interchangeably image either single photon or positron-emitting compounds in a shared software and hardware environment.
  
  
  METHODS
  A mouse is placed in the mid-plane between two identical, opposed, pixelated LYSO arrays separated by 21.8-cm and in time coincidence. An image of the distribution of positron decays in the animal is formed on this mid-plane by coincidence events that fall within a small cone angle perpendicular to the two detectors and within a user-specified energy window. We measured the imaging performance of this device with phantoms and in tests performed in mice injected with various compounds labeled with positron-emitting isotopes.
  
  
  RESULTS
  Representative performance measurements yielded the following results (energy window 250-650keV, cone angle 3.5°): resolution in the image mid-plane, 1.66-mm (FWHM), resolution ±1.5-cm above and below the image plane, 2.2-mm (FWHM), sensitivity: 0.237-cps/kBq (8.76-cps/μCi) (18)F (0.024% absolute). Energy resolution was 15.9% with a linear-count-rate operating range of 0-14.8MBq (0-400μCi) and a corrected sensitivity variation across the field-of-view of <3%. Whole-body distributions of [(18)F] FDG and [(18)F] fluoride were well visualized in mice of typical size.
  
  
  CONCLUSIONS
  Performance measurements and field studies indicate that the PPI is well suited to whole-body positron projection imaging of mice. When integrated into the MONICA gamma camera system, the PPI may be particularly useful early in the drug development cycle where, like MONICA, basic whole-body biodistribution data can direct future development of the agent under study and where logistical factors (e.g., available imaging space, non-portability, and cost) may be limitations.
authors: Molecular Imaging Program, Center for Cancer Research, National Cancer Institute, NIH, Building 10, Room B3B69, MSC1088, Bethesda, MD 20892-1088, USA.
authors: Jurgen
authors: J
authors: Seidel
authors: Wenze
authors: W
authors: Xi
authors: John W
authors: JW
authors: Kakareka
authors: Thomas J
authors: TJ
authors: Pohida
authors: Elaine M
authors: EM
authors: Jagoda
authors: Michael V
authors: MV
authors: Green
authors: Peter L
authors: PL
authors: Choyke
mesh_terms: D000818:Animals; D004583:Electrons; D005459:Fluorides; D019788:Fluorodeoxyglucose F18; D016014:Linear Models; D008187:Lutetium; D051379:Mice; D019047:Phantoms, Imaging; D013997:Time Factors; D051598:Whole Body Imaging / Q000379:methods*
chemical_list: D019788:Fluorodeoxyglucose F18; D008187:Lutetium; D005459:Fluorides
references: IEEE Trans Nucl Sci. 2010 Jun 1;57(3):1038-1044
references: 21165154
references: Bioconjug Chem. 2009 Nov;20(11):2177-84
references: 19919110
references: Phys Med Biol. 2008 Feb 7;53(3):637-53
references: 18199907
references: IEEE Trans Med Imaging. 2000 May;19(5):532-7
references: 11021696
references: Nucl Med Biol. 2010 Apr;37(3):245-53
references: 20346864
references: J Nucl Med. 2007 Oct;48(10):1692-8
references: 17873140